Outcomes of Arterial Allografts Preserved at +2 to +8°C for Revascularization in Septic Settings

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

January 1, 2028

Conditions

Revascularization in a Septic or Potentially Septic Environment

Interventions

PROCEDURE

arterial revascularization

Trial Locations (2)

CHU de Bordeaux, Bordeaux

HCL hopital Louis Pradel, Bron

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER

NCT06963255 - Outcomes of Arterial Allografts Preserved at +2 to +8°C for Revascularization in Septic Settings | Biotech Hunter | Biotech Hunter